These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 71593)

  • 1. Trimethoprim-resistant coliforms.
    Marks PJ; Bruten DM; Speller DC
    Lancet; 1977 Oct; 2(8041):774. PubMed ID: 71593
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimethoprim-resistant coliforms.
    Lacey RW; Bruten DM; Gillespie WA; Lewis EL
    Lancet; 1972 Feb; 1(7747):409-10. PubMed ID: 4110643
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of treatment with trimethoprim-sulfamethoxazole in nonspecific urinary tract infections in pediatric urology].
    Schach H; Scheidt J; Neussel H
    Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):346-9. PubMed ID: 4563169
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The resistance of 150 Klebsiella and E. coli strains isolated from patients suffering from bacteriaemia.
    Brandberg A; Lindblom GB; Franzén C
    Scand J Infect Dis Suppl; 1976; (8):103-5. PubMed ID: 779005
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of co-trimoxazole in sulphonamide-resistant Escherichia coli urinary tract infection.
    Grüneberg RN
    J Antimicrob Chemother; 1975 Sep; 1(3):305-10. PubMed ID: 1102516
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostatitis. Observations on activity of trimethoprim-sulfamethoxazole in the prostate.
    Meares EM
    J Infect Dis; 1973 Nov; 128():Suppl:679-85 p. PubMed ID: 4585967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic studies of multiple resistant strains of Enterobacteriaceae and their plasmids during long-term microbiological survey of hospitals].
    Levashev VS; Belokrysenko SS
    Vestn Akad Med Nauk SSSR; 1985; (10):39-43. PubMed ID: 3909685
    [No Abstract]   [Full Text] [Related]  

  • 10. Carbapenem resistance in a rural part of southern India:
    Sekar R; Srivani S; Amudhan M; Mythreyee M
    Indian J Med Res; 2016 Nov; 144(5):781-783. PubMed ID: 28361833
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in approach to ESBL Enterobacteriaceae among infection control practitioners: results of an Ontario-wide survey.
    Muller M; McGeer A
    Can Commun Dis Rep; 2002 Aug; 28(15):121-4. PubMed ID: 12168403
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of long-term care facility residence on the antibiotic resistance of urinary tract Escherichia coli and Klebsiella.
    Rosello A; Hayward AC; Hopkins S; Horner C; Ironmonger D; Hawkey PM; Deeny SR
    J Antimicrob Chemother; 2017 Apr; 72(4):1184-1192. PubMed ID: 28077671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-trimoxazole in cases of gram-negative septicaemia.
    Brandberg A
    Scand J Infect Dis Suppl; 1976; (8):96-102. PubMed ID: 819991
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Failure of peroral trimethoprim/sulfamethoxazole as infection preventive agent in acute lymphatic leukemia].
    Melby K; Kolmannskog S; Flaegstad T
    Tidsskr Nor Laegeforen; 1984 Nov; 104(31):2174-5. PubMed ID: 6397875
    [No Abstract]   [Full Text] [Related]  

  • 19. [The bioavailability and clinical efficay of drylin, a new drug combination of TMP/SMZ].
    Rilling GJ
    Fortschr Med; 1977 Sep; 95(25):2167-70. PubMed ID: 410716
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.